The emerging peptide market is rapidly growing, and so too are concerns about the safety of these short chains of amino acids as consumers and industries grapple with distinguishing them from supplements. The labels on these gray-market peptides often note that the products are not for everyday use or human consumption, yet there are brands using some of these peptides in their oral supplements.

Oral delivery blurs the line between supplement and gray-market peptides
Venya Patel


